Home
About Us Therapy Development Database
Therapies
Clinical Trials
GDNF History
Ethics
Advocacy & Education Sham Surgery Books Glossary Links News &
Op Eds
 

July 10, 2005
Amgen's GDNF shows signs of effectiveness LA Times, Business Section,
Letter to the Editor
Regarding "Study adds to dispute over drug by Amgen," July 2:

 
 

"Amgen spokeswoman Andrea Rothschild stated that the ability of clinical trial participants with Parkinson's disease to perform day-to-day tasks did not improve when treated with GDNF."

Read the entire letter [12/09; no longer online]

Kristen Suthers
Founder
GDNF4Parkinson's
Washington

 

Copyrightę 2012 Pipeline Project

All rights reserved. Revised: 01/26/12.